Clinical Trials Browser

Bone Marrow Neoplasms × Myeloid × Clear all

Anemia, Bone Marrow Diseases, Hematologic Diseases, Myeloproliferative Disorders, Splenomegaly, Bone Marrow Neoplasms, Primary Myelofibrosis

NCT04217356 2026-01-26

ALLO-BAT

Active not recruiting

90 enrolled

Myeloid

Bone Marrow Neoplasms, Primary Myelofibrosis

NCT07362225 2026-01-23

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

Recruiting

5,000 enrolled

MyeloidOther hematologic neoplasm

Blast Crisis, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Disease Progression, Bone Marrow Neoplasms, Hematologic Neoplasms, Rare Diseases, Primary Myelofibrosis

NCT05423691 2025-04-13

TREG108

Phase 1 Recruiting

24 enrolled

Myeloid

Bone Marrow Diseases, Hematologic Diseases, Myeloproliferative Disorders, Thrombocytosis, Bone Marrow Neoplasms, Primary Myelofibrosis

NCT04709458 2022-05-03

Safety and Early Efficacy Study of TBX-2400 in Patients With AML or Myelofibrosis

Phase 1 Unknown

10 enrolled

MyeloidOther hematologic neoplasm

Leukemia, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Bone Marrow Neoplasms, Primary Myelofibrosis

NCT00113893 2013-11-07

SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes.

Phase 2 Completed

62 enrolled

Myeloid

Bone Marrow Diseases, Hematologic Diseases, Myelodysplastic Syndromes, Bone Marrow Neoplasms

Clinical Trials

Therapeutic RSK1 Targeting in Myelofibrosis

ALLO-BAT

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

TREG108

Safety and Early Efficacy Study of TBX-2400 in Patients With AML or Myelofibrosis

SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes.